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Background
Determination of stem cell behavior in vivo is a major
challenge in the study of normal and leukemic hematopoi-
esis. This requires dynamic tracking of cells in vitro in cell
culture based assays and in vivo in transplantation models.
Most of the existing methods for tracking cells are based
on gene transfers that might modulate the engraftment
and/or leukemogenicity of transplanted cells [1]. In order
to evaluate the use of alternative gene-transfer free meth-
ods, we tested in vitro labeling of leukemic cells using
nanodiamonds (ND). NDs have become the most promis-
ing candidate in recent years due to their excellent bio-
compatibility, chemical stability, scalability, fluorescent
properties and easy functionalization [2].
Materials and methods
Human leukemia cell lines HL60 and K562, grown in
RPMI1640 medium containing 10% fetal bovine serum,
were incubated with different concentrations of 6nm
nanodiamond - phosphate buffered saline- suspension.
Cell viability was assessed using Trypan blue exclusion
method at 24h and 72h of incubation. Flow cytometry was
performed after 24h and 72 h of incubation to detect the
scatter properties of cells. Confocal fluorescence micro-
scopy was performed to detect nanodiamonds after 24 hr
incubation.
Results
No significant cytotoxicity was observed after incubation
of HL60 and K562 cells with up to 10ug/ml ND. Flow
cytometry of cells incubated with ND revealed a dose-
dependent increase in the side scatter properties of the
cells (Figure 1). Confocal microscopy revealed aggregates
of fluorescent ND particles in the cytoplasm of both HL60
and K562 cells confirming the uptake of ND. ND+ K562
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Figure 1 Dose dependent increase in the side scatter of K562 cells
incubated with nanodiamonds (ND).
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cells were sorted using the flow cytometer and cultured.
ND+ cells were detected up to 5 days post sorting, indicat-
ing good retention of these particles.
Conclusions
Our experiments demonstrate for the first time that nano-
diamonds can be used successfully in labeling and in vitro
tracking of leukemic cell lines using flow cytometry and
confocal fluorescence imaging, making them a potential
candidate for studying in vivo tracking in xenograft or
syngenic mouse models of leukemia.
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